Acelyrin SLRN will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Acelyrin to report an earnings per share (EPS) of $-0.80.
Investors in Acelyrin are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings History Snapshot
The company's EPS missed by $0.11 in the last quarter, leading to a 14.71% drop in the share price on the following day.
Here's a look at Acelyrin's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.75 | -0.89 | -0.99 | -0.47 |
| EPS Actual | -0.86 | -0.36 | -0.75 | -0.87 |
| Price Change % | -15.0% | 1.0% | 0.0% | -9.0% |
Stock Performance
Shares of Acelyrin were trading at $6.06 as of November 11. Over the last 52-week period, shares are down 34.48%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for Acelyrin visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
